[ÉÑx yÉÜ à{x yâàâÜx - welcome to urmc · 2016-01-29 · 53,290 cases < age 45 86,940...
TRANSCRIPT
Wendy S. Vitek, MDDirector of Fertility Preservation
Strong Fertility Center
\Ç ~ÇÉãÄxwzx? à{xÜx Áá {ÉÑxA
[ÉÑx yÉÜ à{x YâàâÜx
53,290 cases < age 45
86,940 cases < age 45
American Cancer Society, Surveillance Research, 2013
13,400 cases < age 19
~ 80% interested in future fertility< 30% recall discussing fertility
Fertility preservation consult Fertility risk assessment
Fertility preservation options
Future fertility options
Sexual function
Contraception
Fertility risk assessment Ovarian reserve testing:
Anti‐mullerian hormone (AMH) FSH and estradiol Antral follicle count (AFC)
Options?
Banking options
Oocytes Embryos Ovarian tissue
Oocyte cryopreservation
Menses
Cycle Day
2-3
FSH 150-300 IU
~7 ~12
hCG or GnRH agonist
14
GnRH antagonistGnRH antagonist
Letrozole 5 mg
Options?
Sperm cryopreservation
Limited time to collect
Poor quality
Difficulty ejaculating
Options?
Goossens E et al. Hum. Reprod. 2013;28:897‐907
Testicular tissue cryopreservation
Fertility preservation consult Fertility risk assessment
Fertility preservation options
Future fertility options
Sexual function
Contraception
\Ç ~ÇÉãÄxwzx? à{xÜxËá {ÉÑxA